电邮这篇文章 在发病率上升的第一波和第二波期间，在医学观察站学生观察中一种新型冠状病毒感染的临床过程特点
- 作者: Kuznetsova O.Y.1, Lubimova A.V.1, Ovakimyan K.V.1, Frolova O.I.1, Zamyatina O.S.1, Durkin S.O.1
-
隶属关系:
- North-Western State Medical University named after I.I. Mechnikov
- 期: 卷 25, 编号 1 (2021)
- 页面: 27-33
- 栏目: Original study article
- URL: https://journal-vniispk.ru/RFD/article/view/62649
- DOI: https://doi.org/10.17816/RFD62649
- ID: 62649
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
订阅存取
详细
引言。一种新的冠状病毒感染（COVID-19）在世界范围内的突然出现，给科学界确定该病的主要临床表现以及制定诊断、治疗和预防标准带来了挑战。目前正在研究轻度COVID-19的症状。从这些研究中获得的数据对初级保健医生尤其重要。
这项研究的目的是评估在发病率上升的第一波和第二波期间，被安置在医学观察站的 North-Western State Medical University named after I.I. Mechnikov 大学学生中COVID-19临床过程的特点。
材料和研究方法。这项研究以 North-Western State Medical University named after I.I. Mechnikov 大学医学观察站为基础，分两个阶段进行：2020年4月21日至2020年8月31日（第一波）和2020年9月16日至2020年12月31日（第二波）。所有受试者都有人口统计学、流行病学和临床病史资料。
结果。这项研究涉及309人：39.8%的男性（n = 123）和58.9%的女性（n = 182）。调查对象的平均年龄为21.5±2.6岁。第一波和第二波的受试者人数分别为113人和196人。第二波COVID-19患者平均年龄比第一波低1.5岁，为21.2±2.5岁（p < 0.001）。在COVID-19发病率上升的第二波中，与第一波相比，被观察学生出现以下症状的频率明显增加：干咳、嗅觉丧失、头痛、全身无力、体温升高至38.0℃、鼻塞（p < 0.05）。胸闷、腰痛、体温高于38.0℃等症状的发生率明显降低（p < 0.05）。在第二波中观察到的患者病毒性肺炎的发病率与在第一波中观察到的数据相比显著降低（p < 0.001）。
作者简介
Olga Kuznetsova
North-Western State Medical University named after I.I. Mechnikov
Email: oukuznetsova@mail.ru
ORCID iD: 0000-0002-2440-6959
SPIN 代码: 7200-8861
Scopus 作者 ID: 24448739500
Researcher ID: O-4056-2014
MD, PhD, DSc, Professor
俄罗斯联邦, 41 Kirochnaya str., Saint Petersburg, 191015Anna Lubimova
North-Western State Medical University named after I.I. Mechnikov
Email: lubimova@gmail.com
SPIN 代码: 8967-4868
Researcher ID: O-9927-2014
MD, PhD, DSc, Associate Professor, Professor
俄罗斯联邦, 41 Kirochnaya str., Saint Petersburg, 191015Karina Ovakimyan
North-Western State Medical University named after I.I. Mechnikov
编辑信件的主要联系方式.
Email: ursa-alba@yandex.ru
ORCID iD: 0000-0002-5342-3918
SPIN 代码: 5900-2849
MD, PhD
俄罗斯联邦, 41 Kirochnaya str., Saint Petersburg, 191015Olga Frolova
North-Western State Medical University named after I.I. Mechnikov
Email: frol13-13@list.ru
Resident of the Department of Family Medicine
俄罗斯联邦, 41 Kirochnaya str., Saint Petersburg, 191015Olga Zamyatina
North-Western State Medical University named after I.I. Mechnikov
Email: olyazamiatina@yandex.ru
ORCID iD: 0000-0001-7011-7157
district physician, resident of the Department of Family Medicine
俄罗斯联邦, 41 Kirochnaya str., Saint Petersburg, 191015Svyatoslav Durkin
North-Western State Medical University named after I.I. Mechnikov
Email: durkin.svyatoslav@mail.ru
ординатор кафедры семейной медицины
俄罗斯联邦, 41 Kirochnaya str., Saint Petersburg, 191015参考
- Coronavirus disease 2019. Update April 14, 2020 [Internet]. Available from: https://www.lecturio.com/covid-19-coronavirus-disease-2019. Accessed 24.03.2021.
- Perez-Saez J, Lauer S, Kaiser L, et al. Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland. Lancet Infect Dis. 2020;21(4):e69–e70. doi: 10.1016/S1473-3099(20)30584-3
- Gold MP, Sehayek D, Gabrielli S, et al. COVID-19 and comorbidities: a systematic review and meta-analysis. Postgrad Med. 2020;132(8):749–755. doi: 10.1080/00325481.2020.1786964
- Jain V, Yuan J-M. Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis. Int J Public Health. 2020;65(5):533–546. doi: 10.1007/s00038-020-01390-7
- Vremennye metodicheskie rekomendatsii. Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID–19) [Internet]. Available from: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/054/588/original/Временные_МР_COVID-19_%28v.10%29-08.02.2021_%281%29.pdf. Accessed 24.03.2021. (In Russ.)
- Chakraborty G, Sharma AR, Sharma G, et al. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Eur Rev Med Pharmacol Sci. 2020;24(7):4016–4026. doi: 10.26355/eurrev_202004_20871
- The epidemiological characteristics of an outbreak of 2019 novel Coronavirus Diseases (COVID-19). China CDC Weekly. 2020;2(8):113–122. doi: 10.46234/ccdcw2020.032
- Kuznetsova OYu, Lyubimova AV, Ovakimyan KV, et al. Features of the clinical course of a new coronavirus infection in students who were under observation in the observatory. Russian family doctor. 2020;24(4):5–12. (In Russ.) doi: 10.17816/RFD57155
- Iftimie S, López-Azcona AF, Vallverdú I, et al. First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain [Internet]. Available from: https://doi.org/10.1101/2020.12.10.20246959. Accessed 23.03.2021.
- Sayganov SA, Meltser AV, Liubimova AV, et al. Experience in measures development to prevent spread of new coronavirus disease among students of educational organization living in dormitories. Preventive and clinical medicine. 2020;76(3):4–11. (In Russ.)
- Klinicheskoe issledovanie preparatov dlya lecheniya COVID-19 “Solidarity”. WHO [Internet]. Available from: https://www.who.int/ru/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments. Accessed 23.03.2021.
- EVMS Critical care protocol COVID19 [Internet]. Available from: https://www.evms.edu/media/evms_public/departments/internal_medicine/EVMS_Critical_Care_COVID-19_Protocol.pdf. Accessed 23.03.2021.
- Meng X, Deng Ya, Dai Z, Meng Z. COVID-19 and anosmia: A review based on up-to-date knowledge. Am J Otolaryngol. 2020;41(5):102581. doi: 10.1016/j.amjoto.2020.102581
- Reinhard A, Ikonomidis Ch, Broome M, Gorostidi F. Anosmia and COVID-19. Rev Med Suisse. 2020;16(691-2):849–851. (In French)
- Vaira LA, Salzano G, Fois AG, et al. Potential pathogenesis of ageusia and anosmia in COVID-19 patients. Int Forum Allergy Rhinol. 2020;10(9):1103–1104. doi: 10.1002/alr.22593
补充文件
